Human Tumor Necrosis Factor Receptor Superfamily Member 8 / CD30 (TNFRSF8) Protein
611€ (100 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
Human Tumor Necrosis Factor Receptor Superfamily Member 8 / CD30 (TNFRSF8) Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx692626
tested applications
SDS-PAGE
Description
Human CD30 Protein is a recombinant protein from Human produced in HEK293 Cells. A DNA sequence encoding the human TNFRSF8 (NP_001234.2) extracellular domain (Met 1-Lys 379) was fused with the C-terminal polyhistidine-tagged Fc region of human IgG1 at the C-terminus.
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Proteins and Peptides |
| Immunogen Target | CD30 |
| Host | HEK293 cells |
| Origin | Human |
| Observed MW | Molecular Weight: 66.5 kDa Sequence Fragment: Met1-Lys379 Tag: C-terminal His tag and Fc tag Validity: The validity for this protein is 12 months. |
| Expression | Recombinant |
| Purity | > 90% (SDS-PAGE) |
| Size 1 | 100 µg |
| Size 2 | 200 µg |
| Form | |
| Tested Applications | SDS-PAGE |
| Buffer | Lyophilized from sterile PBS, pH 7.4. |
| Availability | Shipped within 5-15 working days. |
| Storage | Aliquot and store at -20°C or -80°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| NCBI Accession | NP_001234.2 |
| Alias | CD30,Ki-1,D1S166E,CD30L receptor,Lymphocyte activation antigen CD30,Tumor necrosis factor receptor superfamily member 8 |
| Background | Protein TNFRSF8 |
| Status | RUO |
| Note | This product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use. |
Descripción
TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily Member 8), also known as CD30, is a cell surface receptor belonging to the tumor necrosis factor receptor (TNFR) superfamily. This family is composed of receptors that play critical roles in modulating immune responses, inflammation, and apoptosis. CD30 is primarily expressed on activated T and B cells, and its expression is upregulated in certain immune-related diseases and cancers, particularly Hodgkin lymphoma and anaplastic large cell lymphoma (ALCL). It has emerged as a significant target in cancer immunotherapy and as a diagnostic marker for lymphoma. The receptor is a hallmark of classical Hodgkin lymphoma (cHL) and ALCL due to its overexpression on malignant cells. Beyond cancer, CD30 has implications in the regulation of immune homeostasis, playing a role in T-cell activation, differentiation, and proliferation. Dysregulation of CD30 signaling can lead to chronic inflammation and the development of autoimmune disorders, making it an essential molecule of interest in both oncology and immunology.
Related Products
Human TNFRSF8 (Tumor necrosis factor receptor superfamily member 8) ELISA Kit
Ver Producto
Monkey CD30 (Lymphocyte activation antigen CD30) ELISA Kit
Ver Producto